Rejuvenate Biomed

Wetenschapspark 13

3590 Diepenbeek

BE

Rejuvenate Biomed

Foundation date

02/10/2017

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

Rejuvenate Biomed is a Belgian based biomedical company engaged in developing prescription drugs in healthy ageing.
By applying the progress made in geroscience (biology of aging) we identify and develop (up to POC) safe and well tolerated drugs that balance core biological processes associated with age-related functional decline.

Upcoming events

Latest news

  • Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its Board

    Wednesday March 27th 2024

  • InnoSer partners with CR2O to offer an integrated drug discovery to clinical trials pipeline

    Tuesday March 26th 2024

  • Sequana Medical announces three month follow-up data from MOJAVE non-randomized cohort confirming dramatic improvement in diuretic response and virtual elimination of loop diuretics following DSR® therapy

    Monday March 25th 2024